Danaher Corporation Enters into New $5.0 Billion Credit Facility

Details

The Credit Facility, which expires on April 15, 2027, will be used for liquidity support for Danaher's U.S. dollar-denominated commercial paper program and for general corporate purposes. The facility includes interest rates based on Term SOFR and the Federal funds rate, with a margin depending on Danaher's long-term debt credit rating. Danaher is also required to maintain a Consolidated Leverage Ratio of 0.65 to 1.00 or less.

Items reported

About Danaher Corporation

Danaher Corporation is a globally recognized science and technology company specializing in the development, design, and manufacturing of diverse industrial and healthcare products. With a primary focus on innovations in diagnostics, life sciences, dental, and environmental and applied solutions, Danaher serves a multitude of industries and market sectors. Its cutting-edge diagnostic equipment aids medical professionals in delivering precise healthcare, while its life sciences tools and technologies propel biomedical research and development. The company's environmental solutions also play a key role in enhancing water quality analysis and management. Headquartered in Washington, D.C., Danaher is renowned for its strong operational culture exemplified by the Danaher Business System (DBS), which emphasizes continuous improvement and sustainable innovation. This approach has solidified Danaher's presence and influence in both developing specialized solutions and improving efficiency across global markets. The company's strategic acquisitions and consistent focus on innovation have positioned it as a leader in delivering essential solutions that drive significant improvements for healthcare, research, and industrial clients.